Company Filing History:
5 out of 541 
5 out of 37 Years Active: 2019-2025
Title: The Innovative Contributions of Anna DeMarco
Introduction
Anna DeMarco is a prominent inventor based in Bellinzona, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of five patents to her name, her work has the potential to impact the treatment of various infectious diseases.
Latest Patents
Among her latest patents, Anna has developed binding proteins that specifically target O2 and induce opsonophagocytic killing of Klebsiella pneumoniae. This innovation provides methods for reducing, treating, or preventing infections in subjects by administering these binding proteins. Additionally, she has created neutralizing anti-influenza A antibodies that can bind to the hemagglutinin of the influenza A virus, effectively neutralizing multiple subtypes of the virus.
Career Highlights
Throughout her career, Anna has worked with notable companies such as Medimmune Limited and Humabs Biomed SA. Her expertise in antibody development has positioned her as a key player in the biotechnology sector, contributing to advancements in therapeutic solutions.
Collaborations
Anna has collaborated with esteemed colleagues, including Davide Corti and Ebony Benjamin. These partnerships have further enhanced her research and development efforts, leading to innovative solutions in the field.
Conclusion
Anna DeMarco's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in the industry. Her work continues to pave the way for advancements in the treatment of infectious diseases.